Positron emission tomography (PET) is a versatile imaging method that employs positron-emitting radiopharmaceuticals to visualize and measure a variety of biochemical processes. Specifically, dedicated brain PET is considered the gold standard for assessing brain amyloid load, neurofibrillary tau tangles, and glucose hypometabolism, which are crucial in diagnosing Alzheimer's disease (AD) and other dementias. Additionally, brain PET is utilized in fields such as neuro-oncology, epilepsy, and movement disorders. However, there are currently no commercially available dedicated brain PET systems, and the large size and high cost of current whole-body PET scanners restrict the widespread adoption of this technology. This talk aims to introduce the NeuroLF system, which is being developed by the ETH spin-off company Positrigo. NeuroLF seeks to overcome the current limitations of PET by offering a more compact and affordable alternative to conventional whole-body scanners.
Oscar Blanch, Andreu Font Ribera, Lluisa-Maria Mir, Rafel Escribano